CMB 0.00% 0.4¢ cambium bio limited

Ann: Appendix 3Y Change of Director's Interest Notice, page-6

  1. 2,988 Posts.
    lightbulb Created with Sketch. 258
    One of the problems with licencing out tech is that it does not generate capital expansion, just creates a revenue stream. To some extent a company must insources products to create shareholder value.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.